Accuray Incorporated (ARAY): Price and Financial Metrics

Accuray Incorporated (ARAY): $2.70

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

ARAY Price/Volume Stats

Current price $2.70 52-week high $4.30
Prev. close $2.70 52-week low $1.81
Day low $2.69 Volume 395,500
Day high $2.74 Avg. volume 527,366
50-day MA $3.28 Dividend yield N/A
200-day MA $3.07 Market Cap 260.79M

ARAY Stock Price Chart Interactive Chart >

ARAY POWR Grades

  • ARAY scores best on the Value dimension, with a Value rank ahead of 97.14% of US stocks.
  • The strongest trend for ARAY is in Value, which has been heading up over the past 179 days.
  • ARAY's current lowest rank is in the Momentum metric (where it is better than 7.42% of US stocks).

ARAY Stock Summary

  • ACCURAY INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 95.44% of US listed stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 9.13 for ACCURAY INC; that's greater than it is for 87.67% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, ACCURAY INC is reporting a growth rate of 239.06%; that's higher than 94.35% of US stocks.
  • Stocks that are quantitatively similar to ARAY, based on their financial statements, market capitalization, and price volatility, are VNDA, URGN, KOPN, MDRX, and NATI.
  • ARAY's SEC filings can be seen here. And to visit ACCURAY INC's official web site, go to www.accuray.com.

ARAY Valuation Summary

  • ARAY's price/earnings ratio is -28.2; this is 203.49% lower than that of the median Healthcare stock.
  • Over the past 202 months, ARAY's price/sales ratio has gone down 13.9.

Below are key valuation metrics over time for ARAY.

Stock Date P/S P/B P/E EV/EBIT
ARAY 2023-09-18 0.6 4.9 -28.2 -55.3
ARAY 2023-09-15 0.6 4.9 -28.4 -55.6
ARAY 2023-09-14 0.6 5.0 -28.8 -56.2
ARAY 2023-09-13 0.6 4.9 -28.2 -55.3
ARAY 2023-09-12 0.6 4.9 -28.6 -55.9
ARAY 2023-09-11 0.6 4.9 -28.3 -55.5

ARAY Growth Metrics

    Its 3 year revenue growth rate is now at 3.77%.
  • Its 2 year cash and equivalents growth rate is now at 7.21%.
  • The year over year net cashflow from operations growth rate now stands at -83.5%.
ARAY's revenue has moved up $12,077,000 over the prior 34 months.

The table below shows ARAY's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 417.445 -44.379 -11.821
2022-09-30 418.96 6.246 -9.768
2022-06-30 429.909 -2.4 -5.347
2022-03-31 430.822 8.439 -12.987
2021-12-31 437.215 46.109 -12.331
2021-09-30 418.399 32.782 -7.741

ARAY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ARAY has a Quality Grade of C, ranking ahead of 70.31% of graded US stocks.
  • ARAY's asset turnover comes in at 0.83 -- ranking 35th of 186 Medical Equipment stocks.
  • ATRC, INGN, and GKOS are the stocks whose asset turnover ratios are most correlated with ARAY.

The table below shows ARAY's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.830 0.403 -0.014
2021-03-31 0.792 0.409 0.018
2020-12-31 0.785 0.411 0.025
2020-09-30 0.787 0.402 0.042
2020-06-30 0.796 0.391 0.016
2020-03-31 0.866 0.385 0.015

ARAY Price Target

For more insight on analysts targets of ARAY, see our ARAY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $8.20 Average Broker Recommendation 1.3 (Strong Buy)

Accuray Incorporated (ARAY) Company Bio


Accuray Inc. designs, develops, and sells radio-surgery and radiation therapy systems for the treatment of tumors in the body. It offers the CyberKnife System, a robotic stereotactic radio-surgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. The company was founded in 1990 and is based in Sunnyvale, California.


ARAY Latest News Stream


Event/Time News Detail
Loading, please wait...

ARAY Latest Social Stream


Loading social stream, please wait...

View Full ARAY Social Stream

Latest ARAY News From Around the Web

Below are the latest news stories about ACCURAY INC that investors may wish to consider to help them evaluate ARAY as an investment opportunity.

Accuray Opens New Global Training Center at Madison, WI Headquarters to Advance Radiotherapy Treatment Techniques Amid Growing Demand for Precision Cancer Care

Accuray Incorporated (NASDAQ: ARAY) announced today that the company has opened the doors of its new global training facility, the Accuray Center for Education, located at its corporate headquarters in Madison, Wisconsin. The facility is designed for the future and will feature several fully-capable Accuray radiation therapy systems specifically for training, lab spaces with advanced remote learning capabilities and a hybrid, in-person with remote connection option that will enable multiple memb

Yahoo | September 18, 2023

Accuray to Host Investor Day at ASTRO on October 3, 2023

Accuray Incorporated (NASDAQ: ARAY) announced today that the company will host a discussion with analysts and investors on Tuesday, October 3, 2023, in conjunction with the American Society of Radiation Oncology (ASTRO) Annual Meeting. The event will take place in person at the ASTRO meeting and on a virtual platform, with presentations beginning at 1:30 pm PT (4:30 pm ET).

Yahoo | September 14, 2023

Why Is Accuray (ARAY) Down 15.2% Since Last Earnings Report?

Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | September 8, 2023

Accuray Incorporated (NASDAQ:ARAY) is a favorite amongst institutional investors who own 64%

Key Insights Institutions' substantial holdings in Accuray implies that they have significant influence over the...

Yahoo | September 5, 2023

Accuray's (ARAY) Treatment Options to be Boosted Post FDA's Nod

Accuray's (ARAY) latest regulatory approval is likely to improve breast cancer treatment.

Yahoo | August 15, 2023

Read More 'ARAY' Stories Here

ARAY Price Returns

1-mo -3.91%
3-mo -26.03%
6-mo -4.59%
1-year 31.71%
3-year 16.88%
5-year -32.50%
YTD 29.19%
2022 -56.18%
2021 14.39%
2020 47.87%
2019 -17.30%
2018 -20.70%

Continue Researching ARAY

Want to see what other sources are saying about Accuray Inc's financials and stock price? Try the links below:

Accuray Inc (ARAY) Stock Price | Nasdaq
Accuray Inc (ARAY) Stock Quote, History and News - Yahoo Finance
Accuray Inc (ARAY) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!